Recursion Pharmaceuticals | 8-K: Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results
Recursion Pharmaceuticals | DEFA14A: Others
Recursion Pharmaceuticals | 8-K: Current report
Recursion Pharmaceuticals | DEFA14A: Others
Recursion Pharmaceuticals | DEFM14A: Definitive proxy statement relating to merger or acquisition
Recursion Pharmaceuticals | 8-K: Current report
Recursion Pharmaceuticals | DEFA14A: Others
Recursion Pharmaceuticals | DEFA14A: Others
Recursion Pharmaceuticals | DEFA14A: Others
Recursion Pharmaceuticals | 8-K: Current report
Recursion Pharmaceuticals | DEFA14A: Others
Recursion Pharmaceuticals | 8-K: Current report
Recursion Pharmaceuticals | DEFA14A: Others
Recursion Pharmaceuticals | DEFA14A: Others
Recursion Pharmaceuticals | DEFA14A: Others
Recursion Pharmaceuticals | 8-K: Current report
Recursion Pharmaceuticals | 8-K: Current report
Recursion Pharmaceuticals | 8-K: Current report
Recursion Pharmaceuticals | 8-K: Current report
Recursion Pharmaceuticals | 8-K: Current report
No Data
No Data